Chemist and Druggiest invites Pharmacist
Chemist and Druggiest
Post: Pharmacist
[adsense:336x280:8701650588]
Health Ministry decided that academic clinical research may be approved by the Institutional Ethics Committee, however, in the case of new drug is being evaluated or a new use of an existing drug is being evaluated, then approval of DCG(I) is required at 70th meet of DTAB.
The U.S. Food and Drug Administration approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer. Portrazza is marketed by Eli Lilly and Company, based in Indianapolis, Indiana.